From the Department of Plastic and Reconstructive Surgery, MedStar Georgetown University Hospital; Plastic and Reconstructive Surgery, Mt. Sinai Hospital; M. D. Anderson Cancer Center; and the National Center for Plastic Surgery.
Plast Reconstr Surg. 2019 Mar;143(3):495e-503e. doi: 10.1097/PRS.0000000000005373.
Implants offer a method for augmenting abdominal flaps in the setting of deficient volume in breast reconstruction. They may be placed immediately at the time of reconstruction or on a delayed basis. The authors seek to compare outcomes from a single surgeon and previously published studies.
A systematic review was performed, querying multiple databases. A retrospective review was conducted for patients who underwent abdominally based flap breast reconstruction and implant placement between July of 2005 and August of 2015 performed by the senior author (M.Y.N.).
A systematic review of the literature yielded four articles, for a total of 96 patients (142 breasts) included for systematic review. Eighty-seven breasts (61 percent) were reconstructed with immediate implant at the time of flap reconstruction and 55 breasts (39 percent) had a staged approach to implant placement. Complications were noted in 28 breasts (32 percent) following immediate placement and in 10 breasts (18 percent) following staged placement. A total of 53 patients (79 breasts) were retrospectively reviewed, all of whom underwent reconstruction in a staged manner. Twelve breasts (15 percent) were found to have a flap- or implant-related complication; 97.5 percent of implants/flap reconstructions were successful, with a 54 percent revision rate. When pooling systematic and retrospective data, there was a significant difference in complication rates between the staged and immediate reconstruction cohorts (p < 0.001) in favor of the staged approach.
The literature supports a higher rate of implant-related complications following immediate implantation at the time of flap reconstruction. The authors' experience with implant placement highlights the safety and effectiveness of the staged approach.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
在乳房重建中,为了增加腹部皮瓣的体积,可以使用植入物。植入物可以在重建时立即放置,也可以延迟放置。作者旨在比较一位外科医生的结果和之前发表的研究。
进行了系统评价,查询了多个数据库。对 2005 年 7 月至 2015 年 8 月期间由资深作者(M.Y.N.)进行的基于腹部皮瓣的乳房重建和植入物放置的患者进行了回顾性研究。
对文献进行系统评价后,共纳入了 4 篇文章,共计 96 例(142 个乳房)进行系统评价。87 个乳房(61%)在皮瓣重建时立即进行了即刻植入,55 个乳房(39%)采用分期方法放置植入物。即刻放置后有 28 个乳房(32%)出现并发症,分期放置后有 10 个乳房(18%)出现并发症。共回顾性分析了 53 例(79 个乳房)患者,所有患者均采用分期重建。12 个乳房(15%)发现有皮瓣或植入物相关并发症;97.5%的植入物/皮瓣重建成功,修复率为 54%。当系统回顾和回顾性数据合并时,分期和即刻重建队列之间的并发症发生率存在显著差异(p<0.001),分期方法的并发症发生率较低。
文献支持在皮瓣重建时立即植入物与更高的植入物相关并发症发生率相关。作者的植入物放置经验突出了分期方法的安全性和有效性。
临床问题/证据水平:治疗,IV。